Table 3.
Markers of blood pressure at baseline and post-intervention.
| Variables | Intervention group (n = 25) | Control group (n = 25) | p-Value ** | p-Value*** | p-Value**** |
|---|---|---|---|---|---|
| SBP (mmHg) | |||||
| Baseline | 129.44 ± 12.84 | 131.20 ± 17.15 | 0.68 | ||
| After 3 months | 120.84 ± 10.89 | 132.36 ± 16.83 | 0.006 | ||
| p-value* | < 0.001 | 0.27 | |||
| Difference | −8.60 ± 9.32 | 1.16 ± 5.18 | < 0.001 | < 0.001 | |
| DBP (mmHg) | |||||
| Baseline | 86.48 ± 7.48 | 85.92 ± 11.88 | 0.84 | ||
| After 3 months | 82.28 ± 8.24 | 86.40 ± 11.07 | 0.14 | ||
| p-value* | 0.001 | 0.32 | |||
| Difference | −4.20 ± 5.78 | 0.48 ± 2.40 | 0.001 | 0.001 | |
| MAP (mmHg) | |||||
| Baseline | 100.80 ± 7.59 | 101.01 ± 13.00 | 0.94 | ||
| After 3 months | 95.16 ± 7.49 | 101.72 ± 12.33 | 0.02 | ||
| p-value* | < 0.001 | 0.18 | |||
| Difference | −5.64 ± 6.02 | 0.70 ± 2.58 | < 0.001 | < 0.001 | |
| PP (mmHg) | |||||
| Baseline | 42.96 ± 12.47 | 45.48 ± 10.17 | 0.43 | ||
| After 3 months | 38.64 ± 11.37 | 46.36 ± 10.16 | 0.01 | ||
| p-value* | 0.01 | 0.26 | |||
| Difference | −4.32 ± 8.27 | 0.88 ± 3.87 | 0.007 | 0.01 | |
| HR (plus/min) | |||||
| Baseline | 88.40 ± 8.16 | 84.40 ± 8.74 | 0.10 | ||
| After 3 months | 83.04 ± 9.70 | 84.88 ± 8.06 | 0.46 | ||
| p-value* | < 0.001 | 0.18 | |||
| Difference | −5.36 ± 5.67 | 0.48 ± 3.22 | < 0.001 | < 0.001 | |
Values are expressed as means ± SD. *p < 0.05 was considered as significant using Paired t-test. **p < 0.05 was considered as significant using Independent t-test between the two groups at baseline and post-intervention. ***p < 0.05 was considered as significant difference using Independent t-test between the two groups post-intervention. ****p < 0.05 was considered as significant using Analysis of covariance (ANCOVA) between the two groups post-intervention after adjusting for confounding factors.